TrialGynecologic oncology2011

Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Alessandro D Santin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.